Associated Papers
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function.
Strauss MJ et al.
Plos One, 2022
A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
Wang CI et al.
Molecular Pharmacology, 2012
Select a paper to view details